BARBARA MUINA
Allopathic & Osteopathic Physicians|Internal Medicine MIAMI, FL NPI 1295791531
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine FL Novo Nordisk AS All categories
General Payments — all program years on this page
$11,394.40
- Category: General Payments
- Program years: PY2018–2024
- Record count: 654
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,248.71 across 64 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,248.71 | 64 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $178.62 | 11 |
| Insulet Corporation | $178.01 | 8 |
| Acerta Pharma LLC | $139.48 | 7 |
| Lilly USA, LLC | $88.34 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $79.04 | 4 |
| Tandem Diabetes Care, Inc. | $62.07 | 2 |
| Ardelyx, Inc. | $56.67 | 3 |
| Phathom Pharmaceuticals, Inc. | $42.45 | 2 |
| Xeris Pharmaceuticals, Inc. | $41.99 | 2 |
| Medtronic, Inc. | $41.11 | 2 |
| CeQur Corporation | $38.19 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $36.44 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.30 | 2 |
| Abbott Laboratories | $24.92 | 1 |
| PFIZER INC. | $22.40 | 1 |
| E.R. Squibb & Sons, L.L.C. | $22.35 | 1 |
| Ascensia Diabetes Care US Inc. | $20.17 | 1 |
| Astellas Pharma US Inc | $20.07 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.19 | 1 |
| DEXCOM, INC. | $17.93 | 1 |
| SANOFI-AVENTIS U.S. LLC | $17.76 | 1 |
| ABBVIE INC. | $17.64 | 1 |
| Amgen Inc. | $17.01 | 1 |
| Amneal Pharmaceuticals LLC | $16.23 | 1 |
| Kowa Pharmaceuticals America, Inc. | $15.33 | 1 |
By program year
Records — PY2024 (64)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.